HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Guro Valen Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Valen, G. Search for Related Content PubMed Articles by Valen, G. Related Collections Cardiac - other Myocardial protection

Review

Extracardiac approaches to protecting the heart

Department of Physiology, Institute of Basic Medical Sciences, University of Oslo, Postbox 1103 Blindern, 0317 Oslo, Norway

Received 24 October 2008; accepted 15 December 2008.

^_* Corresponding author. Tel.: +47 22851153; fax: +47 22851249. (Email: guro.valen{at}medisin.uio.no).

Myocardial adaptation to ischemia in the form of ischemic preconditioning is clinically attractive, but not easily usable in cardiac surgery until molecular mimics are discovered. The various forms of pre- and postconditioning, including remote preconditioning, indicate that a ‘universal’ protection is evoked. A growing body of evidence indicates that events underlying myocardial adaptation to ischemia may either involve, or be parallel to, signaling of the innate immune response. The heart can be protected through giving cytokines or fragments of bacterial walls. A possible role for cytokines, Toll-like receptors, and nuclear factor kappa B for evoking ischemic preconditioning are discussed. Through stimulating innate immunity, there is potential to bring preconditioning into the clinics in a reasonable time frame. Other approaches to myocardial protection, using cell transfer, gene therapy, and microRNA, are briefly commented on.

Key Words: Preconditioning • Cytokines • Toll-like receptors • Nuclear factor kappa B • Innate immunity • Cell therapy • Gene therapy • MicroRNA